Bright, S A <br/><br/>
Novel pyrrolo-1,5-benzoxazepine compounds display significant activity against resistant chronic myeloid leukaemia cells in vitro, in ex vivo patient samples and in vivo.  [electronic resource] 

 -  British journal of cancer  May 2010 
 - 1474-82 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1532-1827 
<br/><br/><label>Standard No.: </label>10.1038/sj.bjc.6605670  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Blotting, Western<br/>Cell Line, Tumor<br/>Cell Separation<br/>Cell Survival--drug effects<br/>Drug Resistance, Neoplasm--drug effects<br/>Female<br/>Flow Cytometry<br/>Genes, abl--genetics<br/>Humans<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy<br/>Male<br/>Mice<br/>Mice, Inbred BALB C<br/>Middle Aged<br/>Mutation<br/>Oxazepines--pharmacology<br/>Pyrroles--pharmacology